J Korean Soc Radiol.  2014 Nov;71(5):249-253. 10.3348/jksr.2014.71.5.249.

Solitary Axillary Lymph Node Metastasis without Breast Involvement from Ovarian Cancer: Case Report and Brief Literature Review

Affiliations
  • 1Department of Radiology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea. ksj1567@hanmail.net
  • 2Department of Pathology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea.

Abstract

Axillary lymph node metastasis without breast involvement from ovarian cancer is rare. We report a case of a 68-year-old woman proven as ovarian serous papillary carcinoma and metastatic papillary carcinoma of the omentum on surgical diagnostic laparoscopy. In addition, a hypermetabolic lymph node was detected in left axilla and was considered a reactive benign lesion. Mammography and ultrasonography showed no focal lesion in both breasts, but ultrasonography-guided core needle biopsy for the lymph node revealed metastatic serous papillary carcinoma from ovarian origin. Even with a low incidence of axillary lymph node metastasis without breast involvement from ovarian cancer and only marginally elevated standardized uptake value in positron emission tomography, the possibility of metastasis at axillary lymph node in patients with known primary ovarian cancer must be considered.


MeSH Terms

Aged
Axilla
Biopsy, Large-Core Needle
Breast*
Carcinoma, Papillary
Female
Humans
Incidence
Laparoscopy
Lymph Nodes*
Mammography
Neoplasm Metastasis*
Omentum
Ovarian Neoplasms*
Positron-Emission Tomography
Ultrasonography

Figure

  • Fig. 1 Venous phase image of abdominopelvic CT shows bilateral solid and cystic masses (arrows) in both ovaries with massive ascites (*). After the diagnostic laparoscopy, biopsy was proven as ovarian serous papillary carcinoma.

  • Fig. 2 Maximum intensity projection (MIP) image (A) of 18F-FDG PET/CT shows hypermetabolic lesions (SUVmax = 4.9 g/mL, black empty arrows) in both ovarian masses consistent with primary malignancy and hypermetabolism (SUVmax = 4.9 g/mL, white empty arrows) in multiple mesenteric nodules which cannot be ruled out peritoneal seeding. Furthermore, MIP image (A) and axial CT image (B) of 18F-FDG PET/CT show hypermetabolism (SUVmax = 2.1 g/mL) in left axilla (arrows) which might be a reactive benign lymph node. Note.-SUVmax = maximum standardized uptake value, 18F-FDG PET/CT = 18F-fluorodeoxyglucose positron emission tomographic/computed tomography

  • Fig. 3 Photomicrograph of ovary shows papillary structures lining fibrovascular core with psammoma bodies demonstrating serous papillary carcinoma (H&E stain, × 200).

  • Fig. 4 Left breast MLO view of mammography shows two hyperdense enlarged lymph nodes containing central fatty hilums in left axilla (arrows), the largest one size up to 1 cm. Note.-MLO view = mediolateral oblique view

  • Fig. 5 Ultrasonography and photomicrograph image of the left axillary lymph node. A. Breast ultrasonography shows the largest one of three lymph nodes sized up to 1.4 cm, with eccentric cortical thickening and preserved fatty hilum in left axilla. B. Color Doppler ultrasonography shows lymph nodes with prominent hilar blood flow. C. Photomicrograph of left axillary lymph node shows abnormal papillary structures spreading in subcapsular area, which are similar with ovarian papillary lesion (Fig. 3). Normal lymph node structure is noted in the lower portion (H&E, × 100).


Reference

1. Recine MA, Deavers MT, Middleton LP, Silva EG, Malpica A. Serous carcinoma of the ovary and peritoneum with metastases to the breast and axillary lymph nodes: a potential pitfall. Am J Surg Pathol. 2004; 28:1646–1651.
2. Aydin C, Unalp HR, Baloğlu A, Inci AG, Yiğit S, Yavuzcan A. Axillary lymph node metastasis from serous ovarian cancer: a case report and review of the literature. Arch Gynecol Obstet. 2009; 279:203–207.
3. Moore DH, Wilson DK, Hurteau JA, Look KY, Stehman FB, Sutton GP. Gynecologic cancers metastatic to the breast. J Am Coll Surg. 1998; 187:178–181.
4. Murray ME, Given-Wilson RM. The clinical importance of axillary lymphadenopathy detected on screening mammography. Clin Radiol. 1997; 52:458–461.
5. Görkem SB, O'Connell AM. Abnormal axillary lymph nodes on negative mammograms: causes other than breast cancer. Diagn Interv Radiol. 2012; 18:473–479.
6. Shetty MK, Carpenter WS. Sonographic evaluation of isolated abnormal axillary lymph nodes identified on mammograms. J Ultrasound Med. 2004; 23:63–71.
7. Singer C, Blankstein E, Koenigsberg T, Mercado C, Pile-Spellman E, Smith SJ. Mammographic appearance of axillary lymph node calcification in patients with metastatic ovarian carcinoma. AJR Am J Roentgenol. 2001; 176:1437–1440.
8. Lee CH, Giurescu ME, Philpotts LE, Horvath LJ, Tocino I. Clinical importance of unilaterally enlarging lymph nodes on otherwise normal mammograms. Radiology. 1997; 203:329–334.
9. Lin EC, Alavi A. PET and PET/CT: A Clinical Guide. 2nd ed. New York: Thieme Medical Publishers Inc.;2005.
10. Blanchard DK, Farley DR. Retrospective study of women presenting with axillary metastases from occult breast carcinoma. World J Surg. 2004; 28:535–539.
Full Text Links
  • JKSR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr